Lv3
280 积分 2023-04-18 加入
Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non–Small-Cell Lung Cancer: KCSG-LU05-04
3天前
已完结
68Ga-MY6349 PET/CT-guided TROP2-targeted therapy in mCRPC
16天前
已完结
Targeted treatment for unresectable EGFR mutation-positive stage III non-small cell lung cancer: Emerging evidence and future perspectives
24天前
已完结
Recommendations for diagnosis and management of non-small-cell lung carcinoma patients with ex20ins EGFR mutations: insights from a Delphi consensus
24天前
已完结
Navigating the Evolving Landscape of EGFR -Mutated NSCLC
1个月前
已完结
Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progression on platinum-based regimen (DUBLIN-3): a phase 3, international, multicentre, single-blind, parallel group, randomised controlled trial
1个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
1个月前
已完结
Drug-tolerant persister cells in cancer: the cutting edges and future directions
2个月前
已完结
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial
2个月前
已完结
Blood–tumor barrier opening changes in brain metastases from pre to one-month post radiation therapy
2个月前
已完结
皖公网安备34019202002308
